VivoSim Labs Files 8-K with Corporate Updates
Ticker: VIVS · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1497253
| Field | Detail |
|---|---|
| Company | Vivosim Labs, Inc. (VIVS) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing, disclosure
Related Tickers: VIVS
TL;DR
VivoSim Labs (formerly Organovo) filed an 8-K on 4/24/25 detailing corporate changes and disclosures.
AI Summary
VivoSim Labs, Inc. filed an 8-K on April 24, 2025, reporting an amendment to its Articles of Incorporation or Bylaws, a Regulation FD disclosure, and other events. The filing also includes financial statements and exhibits. The company, formerly known as Organovo Holdings, Inc., is based in San Diego, California.
Why It Matters
This 8-K filing indicates significant corporate actions and disclosures by VivoSim Labs, Inc., which could impact investors' understanding of the company's structure and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting corporate actions and disclosures, not indicating immediate financial distress or significant negative events.
Key Numbers
- 001-35996 — SEC File Number (Identifies the company's filing history with the SEC.)
- 27-1488943 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- VivoSim Labs, Inc. (company) — Registrant
- Organovo Holdings, Inc. (company) — Former company name
- April 24, 2025 (date) — Date of report
- April 23, 2025 (date) — Date of earliest event reported
- San Diego, CA (location) — Company address
FAQ
What specific amendments were made to the Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What is the nature of the Regulation FD disclosure?
The filing mentions a Regulation FD disclosure, but the content of this disclosure is not detailed in the provided excerpt.
What other events are being reported in this 8-K?
The filing lists 'Other Events' as a category, but the specific events are not detailed in the provided excerpt.
When did VivoSim Labs, Inc. change its name from Organovo Holdings, Inc.?
The filing indicates a name change from Organovo Holdings, Inc., but the specific date of this change is not provided in the excerpt.
What is the company's fiscal year end?
The company's fiscal year ends on March 31st (0331).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding VivoSim Labs, INC. (VIVS).